Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, L., Small molecule-based Life-span extension therapy: Orphan nuclear receptor NUR77 inhibits senescence and extends life span by down regulating the expression of adenylate cyclase 5 (ADCY5), 20/April/2015, 15.56, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at firstname.lastname@example.org
* Research cooperation
Significance: This study suggests, for the first time, that NUR77, by increasing the expression of its target gene, it may suppress the expression of ADCY5/AC5. Thereby, it may extend the lifespan of an individual. Thus, pharmacological formulations encompassing “NUR77 activators“ may be used to extend the life-span of an an individual.
Undisclosed information: How NUR77 suppresses the expression of adenylate cyclase 5 (ADCY5)